Healthcare - Medical - Diagnostics & Research - NASDAQ - CN
$ 3.75
1.35 %
$ 36.3 M
Market Cap
-0.49
P/E
BALANCE SHEET
1.04 B
ASSETS
272 M
LIABILITIES
768 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Burning Rock Biotech Limited
| Current Assets | 884 M |
| Cash & Short-Term Investments | 629 M |
| Receivables | 168 M |
| Other Current Assets | 87.8 M |
| Non-Current Assets | 156 M |
| Long-Term Investments | 337 K |
| PP&E | 144 M |
| Other Non-Current Assets | 11.4 M |
| Current Liabilities | 263 M |
| Accounts Payable | 18.1 M |
| Short-Term Debt | 8.63 M |
| Other Current Liabilities | 237 M |
| Non-Current Liabilities | 8.23 M |
| Long-Term Debt | 3.69 M |
| Other Non-Current Liabilities | 4.54 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 615.1 | 905.5 | 1 431.3 | 1 895.3 | 94.2 | 93.3 | 54.8 |
| Short Term Investments | 13.4 | 2.1 | 63.8 | 362.1 | 314.0 | 36.8 | 135.2 |
| Receivables | 167.8 | 170.2 | 161.4 | 110.8 | 89.7 | 35.5 | 41.2 |
| Inventory | 69.0 | 130.3 | 123.2 | 68.0 | 58.1 | 49.1 | 16.8 |
| Other Current Assets | 32.2 | 52.8 | 41.2 | 51.1 | 31.9 | 31.4 | 50.9 |
| Total Current Assets | 884.1 | 1 258.8 | 1 820.9 | 2 523.7 | 706.8 | 293.0 | 298.9 |
| PP&E | 144.2 | 300.0 | 406.4 | 111.5 | 89.3 | 69.6 | 60.7 |
| Intangible Assets | 1.0 | 0.2 | 5.2 | 3.5 | 0.3 | 0.5 | 0.5 |
| Goodwill | 0 | 1.8 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0.3 | 0.7 | 0.9 | 1.4 | 40.2 | 2.0 | 37.3 |
| Other Long Term Assets | 5.1 | 26.0 | 45.1 | 23.0 | 11.0 | 7.6 | 2.9 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 1 040.0 | 1 587.5 | 2 278.6 | 2 663.0 | 847.6 | 372.7 | 400.3 |
| LIABILITIES | |||||||
| Accounts Payable | 18.1 | 50.9 | 63.1 | 35.5 | 12.3 | 16.3 | 14.3 |
| Short Term Debt | 8.6 | 37.2 | 37.4 | 46.9 | 44.4 | 178.9 | 14.9 |
| Other Current Liabilities | 84.3 | 162.8 | 120.2 | 76.7 | 47.7 | 30.3 | 48.9 |
| Total Current Liabilities | 263.4 | 411.5 | 372.2 | 241.5 | 164.4 | 284.7 | 78.1 |
| Long Term Debt | 3.7 | 13.6 | 49.3 | 0 | 23.1 | 93.3 | 153.8 |
| Deferred Tax Income | 0 | 0 | 0 | (0.3) | 0 | 0 | 0 |
| Other Liabilities | 4.5 | 4.1 | 11.8 | 0.2 | 1 550.5 | 596.1 | 0 |
| Total Liabilities | 271.6 | 429.1 | 433.3 | 242.0 | 1 739.1 | 976.1 | 231.8 |
| EQUITY | |||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 31 K | 29 K | 28 K |
| Retained Earnings | (3 853.6) | (3 199.9) | (2 228.7) | (1 418.2) | (946.5) | (612.0) | (379.5) |
| Other Accumulative Comprehensive Income/Loss | (161.5) | (165.7) | (207.1) | (167.6) | 9.3 | (14.8) | (10.9) |
| Total Equity | 768.4 | 1 158.3 | 1 845.3 | 2 421.0 | (891.5) | (603.5) | 168.5 |
| Total Liabilities and Equity | 1 040.0 | 1 587.5 | 2 278.6 | 2 663.0 | 847.6 | 372.7 | 400.3 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 10.2 | 103.9 | 104.2 | 68.6 | 86.8 | 22.4 | 82.1 |